The global life science instrumentation market size is projected to grow from an estimated USD 60.0 billion in 2020 to USD 79.9 billion by 2025, at a CAGR of 5.9% during the forecast period.Market growth is driven largely by factors, such as increasing expenditure on research & development by pharmaceutical & biotechnology companies, growing public & private funding for life science research, and rising incidence of target diseases & genetic disorders.The emerging markets and increasing demand for analytical instruments are expected to present avenues of growth for market players.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38By technology, the next-generation sequencing segment is expected to grow at the highest rate during the forecast period Based on technology, the life science instrumentation market is segmented into spectroscopy, chromatography, PCR, immunoassays, lyophilization, liquid handling, clinical chemistry analyzers, microscopy, flow cytometry, next-generation sequencing (NGS), centrifuges, electrophoresis, cell counting, and other technologies.The next-generation sequencing (NGS) segment is expected to grow at the highest CAGR during the forecast period, attributed to the advantages offered by NGS technologies in DNA sequencing, which substantially provides more throughput and minimizes the need for fragment-cloning methods.By type, the molecular spectroscopy segment was the largest contributor to the spectroscopy technologies market in 2019 The market for spectroscopy technologies, by type, comprises mass spectrometry, molecular spectrometry, and atomic spectrometry.Molecular spectrometry accounted for the largest share of the spectrometry technologies market in 2019.The large share could be attributed to the wide application of this technology and the presence of stringent regulatory guidelines for drug development and safety.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=38Asia Pacific is expected to grow at the highest CAGR in the life science instrumentation market during the forecast periodThe Asia Pacific is one of the major revenue-generating regions in the life science instrumentation industry.The strategic expansions by key market players in emerging Asian countries, the growing pharmaceutical industry in India & China, and conferences, exhibitions, & meetings on analytical instruments is driving growth in the region.Key Market Players The vendors operating in the global life science instrumentation market include Agilent Technologies (US), Becton, Dickinson, and Company (US), Bio-Rad Laboratories, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), Eppendorf AG (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Horiba (Japan), Merck KGaA (Germany), PerkinElmer, Inc. (US), Qiagen N.V. (Netherlands), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (US), and Waters Corporation (US).Recent Developments:In 2019, Danaher Corporation (US) signed an agreement with GE Healthcare (US).
3
Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reportsThe Proteomics Global Market Report 2020-30 by The Business Research Company describes and explains the global proteomics market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030.The report evaluates the market across each region and for the major economies within each region.The Proteomics Global Market Report 2021 covers proteomics market drivers, proteomics market trends, proteomics market segments, proteomics market growth rate, proteomics market major players, and proteomics market size.View Complete Report:https://www.thebusinessresearchcompany.com/report/proteomics-market-global-report The proteomics market report provides an in-depth analysis of the impact of COVID-19 on the global proteomics industry, along with revised market numbers due to the effects of the coronavirus and the expected proteomics market growth numbers 2021-2030.Proteomics Global Market Report 2021 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.The chapter also covers markets which have been positively affected by the pandemic.Request For The Sample Now:https://www.thebusinessresearchcompany.com/sample.aspx?id=2828=smp The global proteomics market is expected to grow from $19.96 billion in 2020 to $22.61 billion in 2021 at a compound annual growth rate (CAGR) of 13.3%.The proteomics market is expected to reach $37.88 billion in 2025 at a CAGR of 14%.The report covers the proteomic market segments- 1) By Component: Reagents, Instruments.2) By Instrument: Protein Microarrays, Spectroscopy, X-Ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation.3) By Service And Software: Core Proteomics Services, Bioinformatics Software & Services.About The Business Research Company: The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research.
Market HighlightsBSE (bovine spongiform encephalopathy) is one of the most common neurological disorder found in cattle that results from a transmissible agent called a prion.According to the Centers for Disease Control and Prevention, five cases of BSE are found in the U.S. and 20 in Canada in 2017.Transmissible spongiform encephalopathy (TSEs) or prion diseases are a group of invariably fatal conditions that affect central nervous system (CNS) and more specifically the brain and spinal cord.The most commonly known prion diseases in human are Fatal Familial Insomnia, Creutzfeldt - Jakob disease (CJD), Gerstmann-Straussler-Scheinker Syndrome, and Kuru, and most commonly identified animal prion diseases are Transmissible mink encephalopathy, Bovine Spongiform Encephalopathy (BSE), Scrapie, and others.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/5031A number of factors such as rising facilities for patients affected by encephalopathy, increasing awareness among people, increasing government assistance, and improvement in regulatory framework are propelling the growth of the global spongiform encephalopathy market.It is estimated that spongiform encephalopathy market is expected to grow at a healthy CAGR of 6.1% during the forecast period 2017-2023.SegmentationThe spongiform encephalopathy market is segmented on the basis of type, diagnosis, treatment, and end-user.On the basis of the type, the market is segmented into human and animals.The human segment is classified as Creutzfeldt-Jakob disease, Variant Creutzfeldt-Jakob disease (vCJD), and others.BSE is further classified into classical BSE and atypical BSE.On the basis of the diagnosis, the market is classified into histopathology and immunohistochemistry, immunochemical detection methods, animal bioassays, cell culture assay systems, protein misfolding cyclic amplification, conformation-dependent immunoassay, capillary electrophoresis, fluorescent correlation spectroscopy, multispectral ultraviolet fluorescence spectroscopy, and Fourier transform infrared spectroscopy.
According to the new market research report “Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (Mass Spectrometry, Chromatography), Carbohydrates, Reagents & Chemicals), Application (Disease Diagnostics), End-User (Academic) -Global Forecasts to 2025”, published by MarketsandMarkets™,global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%.This study involved four major activities in estimating the current size of the glycomics market.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.After that, market breakdown and data triangulation procedures were used to determine the extent of segments and subsegments.Key Factors Driving Market Growth:The growth of this market is majorly driven by the increasing research activities on glycomics, rising R investments in pharmaceutical and biotechnology companies, growth in the proteomics market.On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment.However, the high cost of tools is expected to hamper the market growth to a certain extent during the forecast period.Revenue Growth Analysis:The global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%.Don’t miss out on business opportunities in Glycomics / Glycobiology Market :Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the glycomics market.The secondary sources used for this study include the Institute for Glycomics, GLOBOCAN, Biotechnology, and Biological Sciences Research Council, French Society for Electrophoresis and Proteomic Analysis, World Health Organization, International Federation of Pharmaceutical Manufacturers & Associations, Annual Reports, Press Releases, SEC Filings, and Investor Presentations.Browse in-depth TOC on “Glycobiology Market”194 – Tables29 – Figures173 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525The demand for glycomics products for drug discovery & development is estimated to grow at a high rate during the forecast periodBased on application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications.
Market Analysis: Global Needle-Free Injection System MarketGlobal needle-free injection system market is expected to reach USD 42.63 Billion by 2026 and set to witness a substantial CAGR in the forecast period of 2019-2026.This rise in market value can be attributed to extensive use of needle-free injection system in the developing countries.Global Needle-Free Injection System Market By Type (Liquid-Based Needle-Free Injectors, Projectile/Depot-Based Needle-Free Injectors, Powder-Based Needle Free Injectors), Product (Fillable Needle-Free Injectors, Prefilled Needle-Free Injectors), Technology (Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors), Source of Power (Spring-Based Needle-Free Injectors, Gas Propelled/ Air Forced Injector Systems), Usability (Disposable Needle-Free Injectors, Reusable Needle-Free Injectors), Delivery Site (Subcutaneous Injectors, Intramuscular Injectors, Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Others), End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharmaceutical and Biotechnological Companies, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026Download Exclusive Sample Report of Global Needle-Free Injection System [email protected] https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-needle-free-injection-system-marketMarket Definition: Global Needle-Free Injection System MarketNeedle free injection technology is the way to introduce various medicines to patients without penetrating it into the skin.They are used to drive drugs through the skin which includes the forces like Shock waves, pressure by gas, Lorentz or electrophoresis.It has become famous in the emerging countries for its wide used in mass immunization activities, bypassing the chances of needle stick injuries and avoiding other difficulties that are arising due to the multiple use of single needle.Increasing benefits of drug delivery systems is one of major factor contributing growth in the global needle-free injection system market.Market Drivers·       Increasing number of chronic disease is expected to drive the growth of the market in the forecasted period·       Increased rate of communicable disease due to needle stick injuries is expected to drive the growth of the market Increasing demand for self-injection devices is expected to increase growth of the market in the forecasted period·       Increasing demand for biosimilars and vaccination is expected to enhance growth of the marketMarket Restraints·       Limitation in intravenous administration is expected to restrain the market growth·       Stringent regulation is expected to hinder the market growth·       Needle-free injection system is costly which is expected to restrain the market growthTo Insightful Report Details Visit https://www.databridgemarketresearch.com/reports/global-needle-free-injection-system-marketCompetitive Analysis:Global needle-free injection system market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.The report includes market shares of needle-free injection system market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.Key Market Competitors:Few of the major competitors currently working in global needle-free injection system market are Antares Pharma, Endo Pharmaceuticals Inc., PharmaJet, Inovio Pharmaceuticals, Inc., Medical International Technologies, INJEX, THE NATIONAL MEDICAL PRODUCTS CO., LTD, Valeritas, Inc., InsuJet, PenJet, Crossject, Amico Group, BD, Inovio Pharmaceuticals, Inc., MedImmune, Mystic Pharmaceuticals, OptiNose US, Inc., Zogenix, D'Antonio Consultants International, Inc., among others.Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-needle-free-injection-system-marketResearch Methodology: Global Needle-Free Injection System MarketData collection and base year analysis is done using data collection modules with large sample sizes.
According to the new market research report ” Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies)”, published by MarketsandMarkets™, western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).Increasing number of research activities and R spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are expected to drive the growth of the market in the coming years.Key Factors Driving Market Growth:The growth of the overall market can be attributed to the increasing number of research activities and R spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, and growing proteomics market are key factors driving the demand for western blotting instruments and consumables, increasing demand for personalized medicine, and new product launches are some of the other factors driving the growth of this market.Revenue Growth Analysis:The western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).Browse in-depth TOC on “Western Blotting Market”132 – Tables41 – Figures169 – PagesDon’t miss out on business opportunities in Western Blotting Market :In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region.This can be attributed to increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing funding for agriculture research in India, increasing diagnosis and related funding in Australia, and growing prevalence of herpes simplex virus (HSV) in southeast Asia.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711The western blotting market, by product is segmented into instruments and consumables.Consumables segment is expected to account for the largest share of the market, by product in 2016.This segment is also expected to grow at the highest CAGR during the forecast period.The western blotting instruments are further classified into gel electrophoresis instruments, blotting systems, and imagers.However, the imagers segment is expected to grow at the highest CAGR during the forecast period (2016-2021).The global market, based on the application is segmented into biomedical & biochemical research, disease diagnostics, agriculture, disease diagnostics, biologics, and quality control, among others.
Capillary electrophoresis is based on the principle of separation of molecules according to charge and size.Capillary electrophoresis requires small amount of sample which is advantageous in the analysis of rare and expensive sample.Report Overview: https://www.transparencymarketresearch.com/capillary-electrophoresis-systems-market.htmlThe global capillary electrophoresis systems market is driven by advantages of capillary electrophoresis such as efficiency, high accuracy, and greater reproducibility over other molecular techniques and analysis technologies.Rising demand for new therapeutics in drug discovery field has created huge demand for protein and DNA separation method which has increased the demand for capillary electrophoresis systems.However, high cost of equipment and availability of other electrophoresis systems in the market are restraining the capillary electrophoresis systems market.Request a Sample of Capillary Electrophoresis Systems Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=26900The global capillary electrophoresis systems market has been segmented based on product, mode of capillary electrophoresis, application, end-user, and region.Based on mode of capillary electrophoresis, the market has been segmented into capillary zone electrophoresis (CZE), capillary gel electrophoresis (CGE), capillary electro chromatography (CEC), and others.It is the most frequently used technique for protein and DNA separations.
Market HighlightsBSE (bovine spongiform encephalopathy) is one of the most common neurological disorder found in cattle that results from a transmissible agent called a prion.According to the Centers for Disease Control and Prevention, five cases of BSE are found in the U.S. and 20 in Canada in 2017.Transmissible spongiform encephalopathy (TSEs) or prion diseases are a group of invariably fatal conditions that affect central nervous system (CNS) and more specifically the brain and spinal cord.The most commonly known prion diseases in human are Fatal Familial Insomnia, Creutzfeldt - Jakob disease (CJD), Gerstmann-Straussler-Scheinker Syndrome, and Kuru, and most commonly identified animal prion diseases are Transmissible mink encephalopathy, Bovine Spongiform Encephalopathy (BSE), Scrapie, and others.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/5031A number of factors such as rising facilities for patients affected by encephalopathy, increasing awareness among people, increasing government assistance, and improvement in regulatory framework are propelling the growth of the global spongiform encephalopathy market.Despite these drivers, challenges in research and development, and poor healthcare system in low and middle-income countries may hamper the growth of the market.SegmentationThe spongiform encephalopathy market is segmented on the basis of type, diagnosis, treatment, and end-user.On the basis of the type, the market is segmented into human and animals.The human segment is classified as Creutzfeldt-Jakob disease, Variant Creutzfeldt-Jakob disease (vCJD), and others.BSE is further classified into classical BSE and atypical BSE.On the basis of the diagnosis, the market is classified into histopathology and immunohistochemistry, immunochemical detection methods, animal bioassays, cell culture assay systems, protein misfolding cyclic amplification, conformation-dependent immunoassay, capillary electrophoresis, fluorescent correlation spectroscopy, multispectral ultraviolet fluorescence spectroscopy, and Fourier transform infrared spectroscopy.
Protein quantification is the most important step before separation and analysis by electrophoresis or chromatography or any other immunochemical techniques.The use of protein assays for early diagnosis of diseases such as cancer and HIV may significantly reduce the morbidity and mortality of the disease.Thus, use of assay in disease diagnosis, drug discovery and development encourages the biotechnology and pharmaceutical industry to invest in R, which fuels the demand of protein assays market.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5091 Several new biomarker identification systems are launched by the key players which grants various opportunities for the global protein assay market.For instance, in June 2017, Gyros Protein Technologies AB launched a new version of its anti-drug antibody (ADA) solution for the immunogenicity market.This solution enables customers to automatically run the assays in a time-efficient manner using small volumes of patient samples and reagents, and shorten run-times.According to a publication by Pharmaceuticals Research and Manufacturers of America (PhRMA), the organizations spent approximately $58.8 billion on R in 2015 accounted for the largest part of all the biopharmaceutical R spending in the U.S.However, high cost of multiplex assay hardware is limiting the growth of global protein assay market.The global market of protein assays is expected to grow at a CAGR of approximately 10.8% during the forecast period 2017-2023.Intended AudienceProtein Assays SuppliersProtein Assays ManufacturersResearch And Development (R) CompaniesMedical Research LaboratoriesAcademic Medical Institutes and UniversitiesSegmentationThe protein assays is segmented on the basis of type, application, product, technology and end-users.On the basis of type, the market is segmented into copper-ion-based assays, test strip-based assays, dye-binding assays, and others On the basis of application, market is segmented into diagnosis, drug discovery, protein purification and othersOn the basis of product market is segmented into reagents & kits, instruments and othersOn the basis of technology, market is segmented into colorimetric-based protein assays, fluorescence-based protein assays, and absorbance-based protein assaysOn the basis of end-user, the market is segmented into hospitals & diagnostic centers, academic institutes, pharmaceutical & biotechnology companies and others.Regional AnalysisThe global protein assays market consists of countries namely America, Europe, Asia Pacific, and the Middle East.North America is projected to hold the largest share of the global protein assay market due to presence of superior research and development base, strong regional economics, and greater emphasis on disease prevention and wellness by governments.The European protein assay market is expected to witness rapid growth owing to the high investment in various private and government funded research and development programs in the region and increased spending on pharmaceutical and biotechnology industry development.Countries such as China, Japan, and India in Asia Pacific are also poised to be promising markets for protein assay in the near future.India is anticipated to witness an expansion in spending due to a government resolution to enhance healthcare services.
Capillary electrophoresis is based on the principle of separation of molecules according to charge and size.Capillary electrophoresis requires small amount of sample which is advantageous in the analysis of rare and expensive sample.Report Overview: https://www.transparencymarketresearch.com/capillary-electrophoresis-systems-market.htmlThe global capillary electrophoresis systems market is driven by advantages of capillary electrophoresis such as efficiency, high accuracy, and greater reproducibility over other molecular techniques and analysis technologies.Rising demand for new therapeutics in drug discovery field has created huge demand for protein and DNA separation method which has increased the demand for capillary electrophoresis systems.However, high cost of equipment and availability of other electrophoresis systems in the market are restraining the capillary electrophoresis systems market.Request a Sample of Capillary Electrophoresis Systems Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=26900The global capillary electrophoresis systems market has been segmented based on product, mode of capillary electrophoresis, application, end-user, and region.Based on mode of capillary electrophoresis, the market has been segmented into capillary zone electrophoresis (CZE), capillary gel electrophoresis (CGE), capillary electro chromatography (CEC), and others.It is the most frequently used technique for protein and DNA separations.
The scope of the global Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market was appreciated by US$ 5.62 billion in 2016 and it is likely to reach US$ 18.3 billion during the forecast period.Besides, emerging economies need to think twice before affirming pharmacogenomics tests as initial as well as operating costs are high.By application, the segmentation goes like cardiovascular disease, pain management, psychiatry, infectious diseases, oncology, and neurological disease.By technology, the pharmacogenomics technology industry spans sequencing, polymerase chain reaction, mass spectrometry, microarray, and electrophoresis.By end-user, the pharmacogenomics companion diagnostics (CDx) market states research organizations & academic institutes and hospitals and clinics.By geography, it comprises North America, Asia Pacific, LATAM, Europe, and MEA.Regional Insights:North America rules the roost; thanks to extensive investment in healthcare by the U.S. Europe comes in second due to Belgium and Denmark being on the top pedestal with respect to healthcare.
The Electrophoresis Market is expected to reach USD 3.6 billion by 2025 from USD 2.7 billion in 2020, at a CAGR of 6.0% during the forecast period.Factors such as the rising incidence of cancer, infectious diseases, and genetic disorders; growth in funding for research on genomic, proteomic, and electrophoresis techniques; the growing number of industry-academia research collaborations; growing use of capillary electrophoresis with mass spectroscopy; the increasing use of next-generation sequencing; and rise in the number of clinical, forensic, and research laboratories are driving market growth.By product, the electrophoresis reagents segment is expected to account for the largest share of the electrophoresis marketBased on product, the electrophoresis market is segmented into electrophoresis reagents, electrophoresis systems, gel documentation systems, and software.The electrophoresis reagents segment accounted for the largest share of the market in 2019.This is primarily due to the increasing use of consumables in tandem with electrophoresis systems in research fields of proteomics, genomics, drug discovery, antibody development, and personalized medicine, among others.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=434The research segment is expected to witness the rising adoption of electrophoresis systems in the next five years Based on application, the research segment accounted for the largest share of the electrophoresis market, followed by diagnostics and quality control & process validation in 2019.The large share of the research segment is attributed to the increasing application of electrophoresis in the field of drug discovery, proteomics, genomics, and antibody research.North America to dominate the electrophoresis market during the forecast period In 2018, North America dominated the global electrophoresis industry, followed by Europe.The large share of North America can be attributed to the increasing investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=434Leading Companies Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck Group (Germany), Agilent Technologies (US), Danaher Corporation (US), GE Healthcare (US), PerkinElmer (US), QIAGEN N.V. (Netherlands), Harvard Bioscience (US), Shimadzu Corporation (Japan), Lonza Group (Switzerland), Sebia Group (UK), C.B.S.Scientific Company (US), Helena Laboratories (US), Takara Bio (Japan), Syngene (UK), Teledyne Technologies (US), VWR International (US), Analytik Jena (Germany), and TBG Diagnostics Ltd. (Australia).
The report "Life Science Instrumentation Market by Technology [Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR,, Microscopy], Application (Research, Clinical), End User (Pharma-Biotech, Agri and Food Industry, Hospitals & Diagnostic Labs) - Global Forecasts to 2025" The global life science instrumentation market size is projected to reach USD 79.9 billion by 2025 from USD 60.0 billion in 2020, growing at a CAGR of 5.9% during the forecast period.Browse 189 market data Tables and 33 Figures spread through 306 Pages and in-depth TOC on "Life Science Instrumentation Market by Technology [Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR,, Microscopy], Application (Research, Clinical), End User (Pharma-Biotech, Agri and Food Industry, Hospitals & Diagnostic Labs)-Global Forecasts to 2025" View detailed Table of Content here - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38Increasing spending on pharmaceutical R, growing food safety concerns, technological advancements in analytical instruments, and the availability of funding for life science research are fueling the growth of the market.Moreover, rising environmental safety concerns, increasing demand for analytical instruments in several industries, and high demand in emerging nations are some of the other major factors driving the growth of this market.The spectroscopy segment accounted for the largest share of the life science instrumentation market, by technology, in 2019Based on technology, the market is segmented into spectroscopy, chromatography, PCR, immunoassays, lyophilization, liquid handling, clinical chemistry analyzers, microscopy, flow cytometry, next-generation sequencing (NGS), centrifuges, electrophoresis, cell counting, and other technologies.The spectroscopy technology segment accounted for the largest share of the life science instrumentation market during the forecast period.Next-generation sequencing (NGS) to register the highest growth over the forecast period among life science instrumentation technologies The Next-generation sequencing (NGS) segment is expected to register the highest growth over the forecast among the life science research market over the forecast period.The significant growth of this segment is attributed to the advantages offered by NGS technologies in DNA sequencing, which substantially provides more throughput and minimizes the need for fragment-cloning methods.North America to dominate the life science instrumentation market during the forecast periodThe life science instrumentation industry is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.The North American region accounted for the largest share of the life science instrumentation market in 2019.The high adoption rate of novel technologies and the large number of life science research studies conducted in this region.Moreover, stringent drug development regulations, increased funding for life science research activities, and the growing number of metabolomics research studies are some of the major factors driving the growth of the life science instrumentation sector in North America.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=38Leading Companies Agilent Technologies (US), Becton, Dickinson, and Company (US), Bio-Rad Laboratories, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), Eppendorf AG (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Horiba (Japan), Merck KGaA (Germany), PerkinElmer, Inc.. (US), Qiagen N.V. (Netherlands), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc.  (US), and Waters Corporation (US).
This study involved four major activities in estimating the current size of the glycomics market.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.After that, market breakdown and data triangulation procedures were used to determine the extent of segments and subsegments.Key Factors Driving Market Growth:The growth of this market is majorly driven by the increasing research activities on glycomics, rising R investments in pharmaceutical and biotechnology companies, growth in the proteomics market.On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment.However, the high cost of tools is expected to hamper the market growth to a certain extent during the forecast period.Revenue Growth Analysis:The global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%.Don’t miss out on business opportunities in Glycomics / Glycobiology Market :Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the glycomics market.The secondary sources used for this study include the Institute for Glycomics, GLOBOCAN, Biotechnology, and Biological Sciences Research Council, French Society for Electrophoresis and Proteomic Analysis, World Health Organization, International Federation of Pharmaceutical Manufacturers & Associations, Annual Reports, Press Releases, SEC Filings, and Investor Presentations.Browse in-depth TOC on “Glycobiology Market”194 – Tables29 – Figures173 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525The demand for glycomics products for drug discovery & development is estimated to grow at a high rate during the forecast periodBased on application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications.
Protein quantification is the most important step before separation and analysis by electrophoresis or chromatography or any other immunochemical techniques.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5091The use of protein assays for early diagnosis of diseases such as cancer and HIV may significantly reduce the morbidity and mortality of the disease.Thus, use of assay in disease diagnosis, drug discovery and development encourages the biotechnology and pharmaceutical industry to invest in R, which fuels the demand of protein assays market.Several new biomarker identification systems are launched by the key players which grants various opportunities for the global protein assay market.For instance, in June 2017, Gyros Protein Technologies AB launched a new version of its anti-drug antibody (ADA) solution for the immunogenicity market.This solution enables customers to automatically run the assays in a time-efficient manner using small volumes of patient samples and reagents, and shorten run-times.According to a publication by Pharmaceuticals Research and Manufacturers of America (PhRMA), the organizations spent approximately $58.8 billion on R in 2015 accounted for the largest part of all the biopharmaceutical R spending in the U.S.However, high cost of multiplex assay hardware is limiting the growth of global protein assay market.The global protein assays market is expected to grow at a CAGR of approximately 10.8% during the forecast period 2017-2023.SegmentationThe protein assays is segmented on the basis of type, application, product, technology and end-users.On the basis of type, the market is segmented into copper-ion-based assays, test strip-based assays, dye-binding assays, and othersOn the basis of application, market is segmented into diagnosis, drug discovery, protein purification and othersOn the basis of product market is segmented into reagents & kits, instruments and othersOn the basis of technology, market is segmented into colorimetric-based protein assays, fluorescence-based protein assays, and absorbance-based protein assaysOn the basis of end-user, the market is segmented into hospitals & diagnostic centers, academic institutes, pharmaceutical & biotechnology companies and others.Regional AnalysisThe global protein assays market consists of countries namely America, Europe, Asia Pacific, and the Middle East.North America is projected to hold the largest share of the global protein assay market due to presence of superior research and development base, strong regional economics, and greater emphasis on disease prevention and wellness by governments.The European protein assay market is expected to witness rapid growth owing to the high investment in various private and government funded research and development programs in the region and increased spending on pharmaceutical and biotechnology industry development.Countries such as China, Japan, and India in Asia Pacific are also poised to be promising markets for protein assay in the near future.The healthcare expenditure in Asia increased due to an extension of state health care programs and the increasing affluence of the population.
Increasing number of research activities and R spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are expected to drive the growth of the market in the coming years.Key Factors Driving Market Growth:The growth of the overall market can be attributed to the increasing number of research activities and R spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, and growing proteomics market are key factors driving the demand for western blotting instruments and consumables, increasing demand for personalized medicine, and new product launches are some of the other factors driving the growth of this market.Revenue Growth Analysis:The western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).Browse in-depth TOC on “Western Blotting Market”132 – Tables41 – Figures169 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711Don’t miss out on business opportunities in Western Blotting Market :In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region.This can be attributed to increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing funding for agriculture research in India, increasing diagnosis and related funding in Australia, and growing prevalence of herpes simplex virus (HSV) in southeast Asia.Download PDF Brochure:The western blotting market, by product is segmented into instruments and consumables.Consumables segment is expected to account for the largest share of the market, by product in 2016.This segment is also expected to grow at the highest CAGR during the forecast period.The western blotting instruments are further classified into gel electrophoresis instruments, blotting systems, and imagers.The blotting systems segment is expected to account for the largest share of western blotting instruments market, by type in 2016.
(Ehime University) Polyacrylamide gel electrophoresis enables high-resolution separation of proteins extracted from biological samples, but it requires more than one day of pretreatment to recover the separated proteins trapped inside the gel for detection by mass spectrometry. BAC-DROP, our novel electrophoresis technology, uses a dissolvable form of polyacrylamide gel, which allows sample pretreatment to be completed in about 5 hours. The developed technology will enable the rapid diagnosis of viruses and disease protein markers.
2
Gel Documentation Systems Market Overview:The global gel documentation systems market is expected to grow at a CAGR of 3.6% over the forecast period from 2018 to 2023, according to a new report published by Market Research Future (MRFR).Furthermore, the report presents a solid analysis of the market’s likely growth prospects over the forecast period and the factors affecting the market’s growth over the forecast period.Gel documentation systems are used in molecular biology to measure nucleic acids and proteins in media such as cellulose, agarose, and acrylamide.Medical processes making use of gel documentation systems include protein quantification, gel and blot imaging, antibody binding affinities for both monoclonal and polyclonal antibodies, 2D electrophoresis, immunoassay, and nucleic acid quantification.The growing demand for advanced proteomics and genomics research is likely to be a major driver for the global gel documentation systems market over the forecast period, as genomics research has led to solutions for several persistent concerns in the healthcare sector over the last few years and is likely to remain a key tool in the bag for advancing the field of medical research and treatment.The increasing prevalence of genetic disorders is likely to be a major driver for the global gel documentation systems market over the forecast period.The increasing awareness about genetic disorders around the world has led to growth in the funding for research efforts aimed at discovering effective cures for genetic disorders.This is likely to remain a major driver for the global gel documentation systems market over the forecast period, as gel documentation systems play a crucial role in the research processes for formulating cures for genetic diseases.Gel Documentation Systems Market Segmentation:The global gel documentation systems market is segmented on the basis of product, detection technique, application, end user, and region.The global gel documentation systems market is segmented by product into instruments, accessories, and software.
2
Biotechnology reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading.These reagents are used in the field of research, genetics, molecular biology, diagnosis, immunology and bioscience.Biotechnology reagents comprises of technologies such as cell culture, spectrometry, IVD, PCR, chromatography, expression and transfection, flow cytometry, and electrophoresis, and find their application in areas such as immune phenotyping, fluorescent microscopy, DNA analysis and cell cycle analysis.According to the Innovative Research, in U.S., around 65% of biotech companies are involved in drug developed with an intention to serve them for medical purposes and pharmaceuticals.Growing number of biotechnology firms in various countries is expected to act as a driver for the market growth.Global biotechnology reagents market is expected to rise from its initial estimated value of USD 65.82 billion in 2018 to an estimated value of USD 118.53 billion by 2026, registering a CAGR of 7.63% in the forecast period of 2019-2026.This rise in market value can be attributed to the significant investments by private players in biotechnology.To Get This Report at 20% Discount, Click Herehttps://www.databridgemarketresearch.com/toc/?dbmr=global-biotechnology-reagents-marketMarket Drivers and Restraints:Increasing interest in stem cell researchIncreasing usage of reagents in commercial and research fieldsStringent government regulations for the approval of reagentsHigh cost of reagents will act as a restraint for the marketThe major players covered in the Biotechnology Reagents MarketFew of the major competitors currently working in the biotechnology reagents market are Abbott, Agilent Technologies Inc., Danaher, BD, Bio-Rad Laboratories Inc., General Electric, bioMérieux SA, LONZA, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hoefer, Inc., Meridian Bioscience, Inc., PerkinElmer Inc., Merck KGaA, Promega Corporation, Quality Biological, Siemens AG, Bio-Techne, TAKARA HOLDINGS INC., Sysmex Corporation, Tosoh Corporation, WATERS, W. R. Grace & Co.-Conn., Ortho Clinical Diagnostics, Olympus Corporation and Fitzgerald Industries International among others.Major TOC Of The ReportChapter One: Biotechnology Reagents Market OverviewChapter Two: Manufacturers ProfilesChapter Three:  Global Biotechnology Reagents Market  Competition, by PlayersChapter Four: Global Biotechnology Reagents Market Size by RegionsChapter Five: North America Biotechnology Reagents Market Revenue by CountriesChapter Six: Europe Biotechnology Reagents Market Revenue by CountriesChapter Seven: Asia-Pacific Biotechnology Reagents Market Revenue by CountriesChapter Eight: South America Biotechnology Reagents Market Revenue by CountriesGet Detailed Table of Contents @https://www.databridgemarketresearch.com/toc/?dbmr=global-biotechnology-reagents-marketKey Report HighlightsComprehensive pricing analysis based on different product types and regional segmentsMarket size data in terms of revenue and sales volumeDeep insights about regulatory and investment scenarios of the global Biotechnology Reagents Market    Analysis of market effect factors and their impact on the forecast and outlook of the global Biotechnology Reagents Market    The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Biotechnology Reagents Market    A roadmap of growth opportunities available in the global Biotechnology Reagents Market    with the identification of key factorsThe exhaustive analysis of various trends of the global Biotechnology Reagents Market to help identify market developmentsAccess Full Report @  https://www.databridgemarketresearch.com/reports/global-biotechnology-reagents-marketKey Questions Answered in Report:What is the key to the Biotechnology Reagents Market?What will the Biotechnology Reagents Market Demand and what will be Growth?What are the latest opportunities for Biotechnology Reagents Market in the future?What are the strengths of the key players?Browse Related [email protected] Hyperactivity Disorder (ADHD) MarketAvian influenza Drug MarketApraxia Drug Market About Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the marketContact:Data Bridge Market ResearchTel: +1-888-387-2818Email: [email protected]
Increasing number of research activities and R spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are expected to drive the growth of the market in the coming years.Major Growth Drivers:The growth of the overall market can be attributed to the increasing number of research activities and R spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, and growing proteomics market are key factors driving the demand for western blotting instruments and consumables, increasing demand for personalized medicine, and new product launches are some of the other factors driving the growth of this market.Expected Revenue Growth: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711The western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).Accessories to Fuel the Growth of Western Blotting Market :In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region.This can be attributed to increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing funding for agriculture research in India, increasing diagnosis and related funding in Australia, and growing prevalence of herpes simplex virus (HSV) in southeast Asia.Download PDF Brochure:The western blotting market, by product is segmented into instruments and consumables.Consumables segment is expected to account for the largest share of the market, by product in 2016.This segment is also expected to grow at the highest CAGR during the forecast period.The western blotting instruments are further classified into gel electrophoresis instruments, blotting systems, and imagers.The blotting systems segment is expected to account for the largest share of western blotting instruments market, by type in 2016.
More

Top